Kratom Alkaloid Levels Vary Sharply by Region, Vein Color, and Plant Part, Study Finds

Why it matters

Manufacturers, regulators, and consumers rely on kratom products having predictable alkaloid content. This study shows that geographic origin, leaf vein color, and which part of the plant is used produce significant differences in mitragynine and 7-OH levels — findings with direct implications for product standardization and the DEA threshold debate.

The big picture

Kratom's two primary alkaloids, mitragynine (MG) and 7-hydroxymitragynine (7-OH), drive both its reported effects and its regulatory scrutiny. For years, researchers have noted anecdotal alkaloid variability across products, but controlled analytical data comparing geographic origins and plant parts remained limited. This Thai study used validated HPLC-DAD methods to systematically quantify those differences across green- and red-veined leaves and shoots from northern and southern Thailand.

Key findings

• Green-veined leaves contained higher mitragynine concentrations than red-veined leaves
• Northern Thai samples produced higher extraction yields and MG content overall
• Southern Thai samples showed relatively higher 7-OH levels compared to northern samples
• 7-hydroxymitragynine was detected only in leaves — not in shoots
• Shoot material contained higher MG concentrations despite yielding less extract overall
• Differences between ultrasound-assisted and microwave-assisted extraction methods were minimal

What they say

The authors concluded that "significant compositional differences were observed" and that "these findings highlight substantial phytochemical variability relevant to quality standardization of kratom-derived products."

Bottom line

**Where kratom grows, what color its veins are, and which plant part is extracted all meaningfully change its alkaloid profile — making standardized product testing essential, not optional.**